TWI244921B - Oral administration medicine with improving absorbability - Google Patents
Oral administration medicine with improving absorbability Download PDFInfo
- Publication number
- TWI244921B TWI244921B TW091120354A TW91120354A TWI244921B TW I244921 B TWI244921 B TW I244921B TW 091120354 A TW091120354 A TW 091120354A TW 91120354 A TW91120354 A TW 91120354A TW I244921 B TWI244921 B TW I244921B
- Authority
- TW
- Taiwan
- Prior art keywords
- vitamin
- tocopherol
- weight
- fat
- patent application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001313977A JP2003119141A (ja) | 2001-10-11 | 2001-10-11 | 吸収性を向上した経口投与製剤 |
Publications (1)
Publication Number | Publication Date |
---|---|
TWI244921B true TWI244921B (en) | 2005-12-11 |
Family
ID=19132362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW091120354A TWI244921B (en) | 2001-10-11 | 2002-09-05 | Oral administration medicine with improving absorbability |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2003119141A (ja) |
KR (1) | KR20030030882A (ja) |
CN (1) | CN1219514C (ja) |
HK (1) | HK1054695A1 (ja) |
TW (1) | TWI244921B (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4780907B2 (ja) * | 2003-09-30 | 2011-09-28 | 小林製薬株式会社 | 催眠剤組成物 |
JP4721631B2 (ja) * | 2003-09-30 | 2011-07-13 | 小林製薬株式会社 | 催眠剤組成物 |
JP5094899B2 (ja) * | 2010-03-23 | 2012-12-12 | 小林製薬株式会社 | 催眠剤組成物 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61151132A (ja) * | 1984-12-24 | 1986-07-09 | Kanebo Ltd | ビタミンk↓2経口剤の製造法 |
JPS63310827A (ja) * | 1987-06-15 | 1988-12-19 | Sanwa Kagaku Kenkyusho Co Ltd | ニコチン酸誘導体を主剤とする徐放性製剤 |
JPH10130171A (ja) * | 1996-09-04 | 1998-05-19 | Dot:Kk | 経口投与用医薬組成物 |
US6197328B1 (en) * | 1999-08-20 | 2001-03-06 | Dott Research Laboratory | Nasally administrable compositions |
-
2001
- 2001-10-11 JP JP2001313977A patent/JP2003119141A/ja active Pending
-
2002
- 2002-09-05 TW TW091120354A patent/TWI244921B/zh not_active IP Right Cessation
- 2002-09-29 CN CNB021439834A patent/CN1219514C/zh not_active Expired - Fee Related
- 2002-10-07 KR KR1020020060903A patent/KR20030030882A/ko not_active Application Discontinuation
-
2003
- 2003-09-30 HK HK03107057A patent/HK1054695A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1054695A1 (en) | 2003-12-12 |
CN1411812A (zh) | 2003-04-23 |
CN1219514C (zh) | 2005-09-21 |
KR20030030882A (ko) | 2003-04-18 |
JP2003119141A (ja) | 2003-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8703725B2 (en) | Nutritional compositions | |
JP6346896B2 (ja) | カルシウムβ−ヒドロキシ−β−メチルブチレート、タンパク質および低レベルの電解質を含む栄養組成物 | |
TWI429405B (zh) | 用於靜脈營養療法的小兒胺基酸溶液 | |
JP2005529980A (ja) | 代謝ストレスを受けている哺乳動物における異化を治療または予防し、同化を促進する方法及び組成物 | |
JPH11500725A (ja) | ピペリンのバイオアベイラビリティ増強剤としての使用 | |
JP2005505500A (ja) | 無月経及び関連疾患を治療するためのタンパク質及び必須アミノ酸の使用 | |
TW200812594A (en) | Medicine for prevention of and/or recovery from fatigue | |
JP2006241140A (ja) | 肝疾患用栄養組成物 | |
CN106616959A (zh) | 用于器官移植围手术期患者的肠内营养制剂及其制备方法 | |
CN109619308A (zh) | 一种用于提高猫咪免疫力来预防猫鼻之的营养膏配方及其制备方法 | |
TWI244921B (en) | Oral administration medicine with improving absorbability | |
CN105581331B (zh) | 一种补钙营养组合物 | |
BRPI0413618B1 (pt) | xarope multivitamínico para crianças ou adolescentes | |
JP6196847B2 (ja) | 防已含有組成物 | |
JP2004210639A (ja) | 経口栄養剤 | |
JP2011068647A (ja) | アスパラギン酸又はその塩含有固形製剤 | |
JP2014214141A (ja) | 防已含有組成物 | |
CN108719998A (zh) | 一种用于治疗骨关节炎的口服膳食补充药剂 | |
JP5114394B2 (ja) | 疲労回復のための医薬 | |
JPH07267855A (ja) | グルタミン産生剤 | |
JP7489071B2 (ja) | 経口ゲル状組成物 | |
KR20230065181A (ko) | 티아민 또는 그의 유도체와 피돌산 마그네슘을 포함하는 경구용 조성물 및 복합 제제 | |
JP2011068614A (ja) | ビタミン製剤 | |
AU2019305075A1 (en) | Nutritional compositions for enhancement of muscle performance | |
JP2011026312A (ja) | アスパラギン酸又はその塩含有固形製剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |